Adcock Ingram Holdings Limited

Johannesburg Stock Exchange AIP.JO

Adcock Ingram Holdings Limited EBITDA Margin for the year ending June 30, 2024: 14.76%

Adcock Ingram Holdings Limited EBITDA Margin is 14.76% for the year ending June 30, 2024, a 0.23% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Adcock Ingram Holdings Limited EBITDA Margin for the year ending June 30, 2023 was 14.72%, a 2.27% change year over year.
Adcock Ingram Holdings Limited EBITDA Margin for the year ending June 30, 2022 was 14.39%, a 6.44% change year over year.
Adcock Ingram Holdings Limited EBITDA Margin for the year ending June 30, 2021 was 13.52%, a -6.87% change year over year.
Adcock Ingram Holdings Limited EBITDA Margin for the year ending June 30, 2020 was 14.52%, a -2.72% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

Johannesburg Stock Exchange: AIP.JO

Adcock Ingram Holdings Limited

CEO	Mr. Andrew Gideon Hall CA (SA), BPharm
IPO Date	March 6, 2000
Location	South Africa
Headquarters	1 New Road
Employees	2,549
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Personal Care

Description

Adcock Ingram Holdings Limited manufactures, markets, and distributes healthcare products in South Africa, the United States, Canada, the United Kingdom, rest of Europe, and internationally. It offers a portfolio of over the counter products, prescription medicines, and consumer products, as well as instrumentation and surgical products. The company also provides pharmaceutical products in a range of therapeutic classes, such as women's health, cannabidiol, antiretroviral, dermatology, central nervous system, respiratory, ophthalmology, generics, cardiovascular, pain, gastroenterology, energy supplements, colds and flu, personal care, feminine hygiene, digestive well-being, allergies, baby care, cough, food and nutrition supplements, vitamins, and minerals supplements. In addition, it manufactures and supplies hospital and critical care products, including intravenous solutions, renal dialysis systems, and blood collection products. The company serves private and public sectors. Adcock Ingram Holdings Limited was founded in 1890 and is headquartered in Midrand, South Africa.

Key trends

Past 5 years